ASK REDCHAT ANYTHING ABOUT RELMADA THERAPEUTICS INC.
Relmada Therapeutics Inc. (NASDAQ: RLMD)
Listen to this Section
$6.80
+0.1450
(
+2.18% )
1.8M
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| REL-1017DetailsMajor depressive disorder, Mental health |
Phase 3 |
| Psilocybin (REL-P11)DetailsObesity, Metabolic disorder |
Phase 1 |
| REL-P11DetailsObesity, Metabolic disorder |
Phase 1 |
Market Data
|
| Open |
$6.80 |
| Previous Close |
$6.65 |
| Volume |
1.8M |
| Market Cap |
$697.52M |
| Day Range |
$6.54 - $6.97 |
| 52 Week Range |
$0.52 - $8.00 |
| Shares Outstanding |
104.89M |
| Change % |
+2.18% |
| Net Change |
▲ 0.1450 |
| Insider Ownership |
0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2014 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
1,119,246.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-09-11 |
Buy |
25000.00 |
Kelly Paul Edward |
| 2024-09-11 |
Buy |
55579.00 |
TRAVERSA SERGIO |
| 2024-09-11 |
Buy |
13000.00 |
CASAMENTO CHARLES J |
| 2024-09-11 |
Buy |
8194.00 |
Shenouda Maged |
| 2024-05-29 |
Sale |
-20976.00 |
GLASSPOOL JOHN |
| 2024-05-29 |
Sale |
-43700.00 |
Kelly Paul Edward |
| 2024-05-29 |
Sale |
-54624.00 |
Shenouda Maged |
| 2024-05-29 |
Sale |
-122358.00 |
TRAVERSA SERGIO |
| 2024-05-29 |
Sale |
-20976.00 |
Fedeli Fabiana |
| 2024-05-29 |
Sale |
-54624.00 |
Ence Chuck |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| schedule |
Other |
2 |
Nov 14, 2025 |
| 10-q |
Quarterly Reports |
60 |
Nov 13, 2025 |
| 8-k |
8K-related |
54 |
Nov 13, 2025 |
| 4 |
Insider transactions |
1 |
Nov 06, 2025 |
| 4 |
Insider transactions |
1 |
Nov 06, 2025 |
| 4 |
Insider transactions |
1 |
Nov 06, 2025 |
| 4 |
Insider transactions |
1 |
Nov 06, 2025 |
| 8-k |
8K-related |
19 |
Nov 05, 2025 |
| 8-k |
8K-related |
54 |
Nov 04, 2025 |
| 8-k |
8K-related |
45 |
Sep 17, 2025 |